AP1826A - A controlled release pharmaceutical composition and a process for preparing the same - Google Patents

A controlled release pharmaceutical composition and a process for preparing the same

Info

Publication number
AP1826A
AP1826A AP2006003597A AP2006003597A AP1826A AP 1826 A AP1826 A AP 1826A AP 2006003597 A AP2006003597 A AP 2006003597A AP 2006003597 A AP2006003597 A AP 2006003597A AP 1826 A AP1826 A AP 1826A
Authority
AP
ARIPO
Prior art keywords
preparing
same
pharmaceutical composition
controlled release
release pharmaceutical
Prior art date
Application number
AP2006003597A
Other languages
English (en)
Other versions
AP2006003597A0 (en
Inventor
Himadri Sen
Suryakumar Jayanthi
Vineeth Raghavan
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of AP2006003597A0 publication Critical patent/AP2006003597A0/xx
Application granted granted Critical
Publication of AP1826A publication Critical patent/AP1826A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2006003597A 2003-10-01 2004-09-29 A controlled release pharmaceutical composition and a process for preparing the same AP1826A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN417MU2003 2003-10-01
PCT/IN2004/000306 WO2005048978A2 (en) 2003-10-01 2004-09-29 A controlled release pharmaceutical composition and a process for preparing the same

Publications (2)

Publication Number Publication Date
AP2006003597A0 AP2006003597A0 (en) 2006-04-30
AP1826A true AP1826A (en) 2008-02-08

Family

ID=34611194

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003597A AP1826A (en) 2003-10-01 2004-09-29 A controlled release pharmaceutical composition and a process for preparing the same

Country Status (13)

Country Link
US (1) US20070231385A1 (de)
EP (1) EP1673072B1 (de)
CN (1) CN1863512A (de)
AP (1) AP1826A (de)
AT (1) ATE358470T1 (de)
BR (1) BRPI0415322A (de)
DE (1) DE602004005734T2 (de)
EA (1) EA008944B1 (de)
ES (1) ES2286716T3 (de)
MX (1) MXPA06003479A (de)
UA (1) UA82564C2 (de)
WO (1) WO2005048978A2 (de)
ZA (1) ZA200603421B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104267A1 (en) * 2005-04-25 2011-05-05 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
WO2008154234A2 (en) 2007-06-08 2008-12-18 Boehringer Ingelheim International Gmbh Extended release formulation of nevirapine
EP2923582B1 (de) * 2009-07-14 2018-03-21 Hill's Pet Nutrition, Inc. Haustierfutterzusammensetzung mit liponsäure mit verzögerter freisetzung
CN102247332B (zh) * 2011-01-27 2015-03-25 济南久创化学有限责任公司 一种拉米夫定片及其制备方法
CN102225069B (zh) * 2011-04-29 2013-05-08 陶珍珠 一种耐药性显著降低的药物组合物及其制备方法和其应用
EP2714045A1 (de) * 2011-05-30 2014-04-09 Cipla Limited Pharmazeutische antiretrovirale zusammensetzung
WO2013111147A1 (en) * 2011-12-19 2013-08-01 Hetero Research Foundation Extended release compositions of nevirapine
CN107334743B (zh) * 2016-07-15 2020-04-21 安徽贝克生物制药有限公司 一种齐多夫定、拉米夫定、奈韦拉平复方片及其制备方法
CN114392239B (zh) * 2022-01-10 2023-06-27 安徽贝克生物制药有限公司 一种拉米夫定、齐多夫定和依非韦伦的复方片及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018383A2 (en) * 1998-09-28 2000-04-06 Glaxo Group Limited Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester
US6177435B1 (en) * 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (de) * 1956-03-27
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
ZA200110500B (en) * 2001-05-11 2002-04-03 Cipla Medpro Pty Ltd Pharmaceutical composition.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177435B1 (en) * 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
WO2000018383A2 (en) * 1998-09-28 2000-04-06 Glaxo Group Limited Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester

Also Published As

Publication number Publication date
CN1863512A (zh) 2006-11-15
EA200600679A1 (ru) 2006-08-25
ATE358470T1 (de) 2007-04-15
EP1673072A2 (de) 2006-06-28
AP2006003597A0 (en) 2006-04-30
WO2005048978A3 (en) 2006-02-23
BRPI0415322A (pt) 2006-12-05
UA82564C2 (uk) 2008-04-25
MXPA06003479A (es) 2006-06-08
DE602004005734T2 (de) 2007-12-27
ES2286716T3 (es) 2007-12-01
US20070231385A1 (en) 2007-10-04
EP1673072B1 (de) 2007-04-04
WO2005048978A2 (en) 2005-06-02
EA008944B1 (ru) 2007-10-26
ZA200603421B (en) 2007-09-26
DE602004005734D1 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
EP1523994A4 (de) Medizinische zusammensetzung zur regulierung der freisetzung und verfahren zu deren herstellung
IL165511A0 (en) A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
TWI347202B (en) Controlled release preparation
EP1187602A4 (de) Injizierbare pharmazeutische zusammensetzung mit verzögerter freisetzung und verfahren zu deren herstellung
EG24142A (en) Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition
IL178195A0 (en) Tetrahydroquinoline derivatives and a process for preparing the same
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
IL175363A0 (en) Urea derivative and process for preparing the same
EP1706412A4 (de) Neue pyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
TWI370145B (en) Water-soluble polyhydroxyaminoether and process for preparing the same
EG24479A (en) Modified release pharmaceutical formulation
IL178194A0 (en) Tetrahydronaphthyridine derivatives and a process for preparing the same
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
GB2426704B (en) Herbal oro-dental care composition and process for preparing the same
PL373328A1 (en) Sustained release pharmaceutical prepartations and methods for producing the same
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
PL376840A1 (pl) Kompozycja farmaceutyczna o przedłużonym uwalnianiu
IL150910A0 (en) Agrochemical composition containing phosphite and process for the preparation thereof
LT1729739T (lt) Kietos farmacinės kompozicijos gamybos būdas
EP1731139A4 (de) Pharmazeutische zubereitung vom s/o typ und herstellungsverfahren dafür
AP1826A (en) A controlled release pharmaceutical composition and a process for preparing the same
EP1484056A4 (de) Zubereitungen mit verzögerter freisetzung und verfahren für ihre herstellung
EP1834624A4 (de) Medizinische zusammensetzung und herstellungsverfahren dafür